Výsledky vyhľadávania - "Peptide Fragments/blood"

  1. 1
  2. 2

    Zdroj: Osteoporos Int
    Bhattoa, H P, Vasikaran, S, Trifonidi, I, Kapoula, G, Lombardi, G, Jørgensen, N R, Pikner, R, Miura, M, Chapurlat, R, Hiligsmann, M, Haarhaus, M, Evenepoel, P, Jørgensen, H M S, Herrmann, M, Kaufman, J M, Clark, P, Tuzun, Ş, Al-Daghri, N, Silverman, S, Alokail, M S, Ormarsdóttir, S, Yerro, M C P, Matijevic, R, Laslop, A, Rosa, M M C D S, Zakraoui, L, Burlet, N, McCloskey, E, Harvey, N C, Radermecker, R P, Fusaro, M, Torre, C, Kanis, J A, Rizzoli, R, Reginster, J Y, Makris, K & Cavalier, E 2025, 'Update on the role of bone turnover markers in the diagnosis and management of osteoporosis : a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)', Osteoporosis International, vol. 36, no. 4, 513925, pp. 579-608. https://doi.org/10.1007/s00198-025-07422-3
    Bhattoa, H P, Vasikaran, S, Trifonidi, I, Kapoula, G, Lombardi, G, Jørgensen, N R, Pikner, R, Miura, M, Chapurlat, R, Hiligsmann, M, Haarhaus, M, Evenepoel, P, Jørgensen, H S, Herrmann, M, Kaufman, J-M, Clark, P, Tuzun, Ş, Al-Daghri, N, Silverman, S, Alokail, M S, Ormarsdóttir, S, Yerro, M C P, Matijevic, R, Laslop, A, da Silva Rosa, M M C, Zakraoui, L, Burlet, N, McCloskey, E, Harvey, N C, Radermecker, R P, Fusaro, M, Torre, C, Kanis, J A, Rizzoli, R, Reginster, J-Y, Makris, K & Cavalier, E 2025, ' Update on the role of bone turnover markers in the diagnosis and management of osteoporosis : a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) ', Osteoporosis International, vol. 36, no. 4, pp. 579-608 . https://doi.org/10.1007/s00198-025-07422-3
    Bhattoa, H P, Vasikaran, S, Trifonidi, I, Kapoula, G, Lombardi, G, Jørgensen, N R, Pikner, R, Miura, M, Chapurlat, R, Hiligsmann, M, Haarhaus, M, Evenepoel, P, Jørgensen, H S, Herrmann, M, Kaufman, J M, Clark, P, Tuzun, Ş, Al-Daghri, N, Silverman, S, Alokail, M S, Ormarsdóttir, S, Yerro, M C P, Matijevic, R, Laslop, A, da Silva Rosa, M M C, Zakraoui, L, Burlet, N, McCloskey, E, Harvey, N C, Radermecker, R P, Fusaro, M, Torre, C, Kanis, J A, Rizzoli, R, Reginster, J Y, Makris, K & Cavalier, E 2025, 'Update on the role of bone turnover markers in the diagnosis and management of osteoporosis : a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)', Osteoporosis International, vol. 36, no. 4, pp. 579-608. https://doi.org/10.1007/s00198-025-07422-3

    Popis súboru: application/pdf

  3. 3

    Zdroj: Revista espanola de cardiologia, vol. 78, no. 2, pp. 107-116
    Tran, Fabian; Ruperti-Repilado, Francisco Javier; Haaf, Philip; Ayala, Pedro Lopez; Greutmann, Matthias; Schwerzmann, Markus; Bouchardy, Judith; Gabriel, Harald; Stambach, Dominik; Schwitter, Juerg; Wustmann, Kerstin; Freese, Michael; Mueller, Christian; Tobler, Daniel (2024). NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification? (In Press). Revista española de cardiología-English Edition Elsevier Doyma 10.1016/j.rec.2024.05.006 <http://dx.doi.org/10.1016/j.rec.2024.05.006>
    Tran, Fabian; Ruperti-Repilado, Francisco Javier; Haaf, Philip; Ayala, Pedro Lopez; Greutmann, Matthias; Schwerzmann, Markus; Bouchardy, Judith; Gabriel, Harald; Stambach, Dominik; Schwitter, Juerg; Wustmann, Kerstin; Freese, Michael; Mueller, Christian; Tobler, Daniel (2025). NT-proBNP in systemic right ventricles: a new cutoff level for risk stratification? Revista española de cardiología-English Edition, 78(2), pp. 107-116. Elsevier Doyma 10.1016/j.rec.2024.05.006 <http://dx.doi.org/10.1016/j.rec.2024.05.006>

    Popis súboru: application/pdf; ZORA_270755.pdf - application/pdf

  4. 4
  5. 5

    Zdroj: Cardiovasc Diabetol
    Cardiovascular Diabetology, Vol 24, Iss 1, Pp 1-12 (2025)

  6. 6
  7. 7

    Zdroj: Pediatr Res
    Neumann, Roland P; Gerull, Roland; Hasler, Pascal W; Wellmann, Sven; Schulzke, Sven M (2024). Vasoactive peptides as biomarkers for the prediction of retinopathy of prematurity. Pediatric research, 95(7), pp. 1868-1874. Nature Publishing Group 10.1038/s41390-024-03091-w <http://dx.doi.org/10.1038/s41390-024-03091-w>

    Popis súboru: application/pdf

  8. 8

    Zdroj: Osteoporosis International, 36 (4), 579 - 608 (2025-04)

    Relation: https://link.springer.com/content/pdf/10.1007/s00198-025-07422-3.pdf; urn:issn:0937-941X; urn:issn:1433-2965

  9. 9
  10. 10
  11. 11

    Zdroj: Alzheimers Res Ther
    Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-12 (2024)
    Alzheimer's research & therapy 16(1), 279 (2024). doi:10.1186/s13195-024-01647-w

    Predmety: blood [Frontotemporal Dementia], Male, 0301 basic medicine, blood [Neurofilament Proteins], Mass Spectrometry, diagnosis [Frontotemporal Dementia], 0302 clinical medicine, Neurofilament Proteins, blood [Amyloid beta-Peptides], blood [Glial Fibrillary Acidic Protein], Alzheimer Disease/blood [MeSH], Frontotemporal lobar degeneration, Aged, 80 and over [MeSH], Aged [MeSH], Amyloid-beta, Blood biomarker, Mass spectrometry, Frontotemporal Dementia/diagnosis [MeSH], Diagnosis, Differential [MeSH], Differential diagnosis, Alzheimer Disease/diagnosis [MeSH], Alzheimer's disease, Male [MeSH], Neurofilament Proteins/blood [MeSH], Peptide Fragments/blood [MeSH], tau Proteins/blood [MeSH], tau Proteins/cerebrospinal fluid [MeSH], Dementia, Female [MeSH], Biomarkers/blood [MeSH], Humans [MeSH], Glial Fibrillary Acidic Protein/blood [MeSH], Frontotemporal Dementia/blood [MeSH], Middle Aged [MeSH], Research, Mass Spectrometry/methods [MeSH], Immunoprecipitation/methods [MeSH], Amyloid beta-Peptides/blood [MeSH], Aged, 80 and over, ddc:610, blood [Biomarkers], diagnosis [Alzheimer Disease], Middle Aged, amyloid beta-protein (1-42), blood [Peptide Fragments], Frontotemporal Dementia, Female, RC321-571, blood [tau Proteins], Neurosciences. Biological psychiatry. Neuropsychiatry, tau Proteins, Diagnosis, Differential, 03 medical and health sciences, blood [Alzheimer Disease], Alzheimer Disease, Glial Fibrillary Acidic Protein, Humans, Immunoprecipitation, neurofilament protein L, RC346-429, Aged, Amyloid beta-Peptides, methods [Mass Spectrometry], GFAP protein, human, amyloid beta-protein (1-40), Peptide Fragments, cerebrospinal fluid [tau Proteins], Neurology. Diseases of the nervous system, Biomarkers, methods [Immunoprecipitation]

    Popis súboru: application/pdf

  12. 12

    Zdroj: Alzheimers Res Ther
    Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-13 (2024)

  13. 13
  14. 14

    Zdroj: Eur J Pediatr

  15. 15

    Zdroj: Trials
    Trials, Vol 25, Iss 1, Pp 1-12 (2024)
    Kunkel, J B, Holle, S L D, Hassager, C, Pecini, R, Wiberg, S, Palm, P, Holmvang, L, Bang, L E, Kjærgaard, J, Thomsen, J H, Engstrøm, T, Møller, J E, Lønborg, J T, Frydland, M & Søholm, H 2024, ' Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T) : study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial ', Trials, vol. 25, no. 1, 739 . https://doi.org/10.1186/s13063-024-08573-0

    Popis súboru: application/pdf

  16. 16

    Zdroj: Trials
    Trials, Vol 25, Iss 1, Pp 1-12 (2024)
    Holle, S L D, Kunkel, J B, Hassager, C, Pecini, R, Wiberg, S, Palm, P, Holmvang, L, Bang, L E, Kjærgaard, J, Thomsen, J H, Engstrøm, T, Møller, J E, Lønborg, J T, Søholm, H & Frydland, M 2024, ' Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial) : study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial ', Trials, vol. 25, no. 1, 731 . https://doi.org/10.1186/s13063-024-08567-y

    Popis súboru: application/pdf

  17. 17

    Prispievatelia: Jan Verwerft Jan Stassen Maarten Falter a ďalší

    Zdroj: J Am Heart Assoc
    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 15 (2024)
    Journal of the American Heart Association : Cardiovascular and cerebrovascular disease

  18. 18

    Zdroj: BMC Nephrol
    BMC Nephrology, Vol 25, Iss 1, Pp 1-16 (2024)
    Davies, E M, Buckley, B J R, Austin, P, Lip, G Y H, Oni, L, McDowell, G & Rao, A 2024, 'Routine cardiac biomarkers for the prediction of incident major adverse cardiac events in patients with glomerulonephritis: a real-world analysis using a global federated database', BMC Nephrology, vol. 25, no. 1, 233. https://doi.org/10.1186/s12882-024-03667-y

    Popis súboru: application/pdf

  19. 19

    Zdroj: Alzheimers Res Ther
    Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-10 (2024)

  20. 20